Howe & Rusling’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-521
| Closed | -$54K | – | 1068 |
|
|
2022
Q3 | $54K | Sell |
521
-4
| -0.8% | -$439 | 0.01% | 318 |
|
|
2022
Q2 | $55K | Sell |
525
-3
| -0.6% | -$356 | 0.01% | 303 |
|
|
2022
Q1 | $68K | Sell |
528
-16
| -3% | -$1.93K | 0.01% | 291 |
|
|
2021
Q4 | $67K | Hold |
544
| – | – | 0.01% | 294 |
|
|
2021
Q3 | $77K | Sell |
544
-31
| -5% | -$4.56K | 0.01% | 265 |
|
|
2021
Q2 | $90K | Buy |
575
+35
| +6% | +$5.67K | 0.01% | 243 |
|
|
2021
Q1 | $84K | Sell |
540
-4
| -0.7% | -$620 | 0.01% | 253 |
|
|
2020
Q4 | $81K | Buy |
544
+1
| +0.2% | +$141 | 0.01% | 245 |
|
|
2020
Q3 | $72K | Hold |
543
| – | – | 0.01% | 232 |
|
|
2020
Q2 | $63K | Buy |
543
+6
| +1% | +$691 | 0.01% | 231 |
|
|
2020
Q1 | $53K | Sell |
537
-5
| -0.9% | -$655 | 0.01% | 251 |
|
|
2019
Q4 | $79K | Hold |
542
| – | – | 0.01% | 249 |
|
|
2019
Q3 | $72K | Buy |
542
+7
| +1% | +$904 | 0.01% | 262 |
|
|
2019
Q2 | $61K | Buy |
535
+1
| +0.2% | +$117 | 0.01% | 277 |
|
|
2019
Q1 | $66K | Buy |
534
+1
| +0.2% | +$114 | 0.01% | 266 |
|
|
2018
Q4 | $54K | Buy |
533
+7
| +1% | +$787 | 0.01% | 254 |
|
|
2018
Q3 | $67K | Buy |
526
+2
| +0.4% | +$238 | 0.01% | 235 |
|
|
2018
Q2 | $57K | Hold |
524
| – | – | 0.01% | 246 |
|
|
2018
Q1 | $56K | Sell |
524
-1
| -0.2% | -$116 | 0.01% | 264 |
|
|
2017
Q4 | $62K | Sell |
525
-4
| -0.8% | -$452 | 0.01% | 279 |
|
|
2017
Q3 | $60K | Sell |
529
-26
| -5% | -$3K | 0.01% | 283 |
|
|
2017
Q2 | $69K | Sell |
555
-4
| -0.7% | -$474 | 0.01% | 236 |
|
|
2017
Q1 | $66K | Buy |
559
+1
| +0.2% | +$113 | 0.01% | 233 |
|
|
2016
Q4 | $56K | Sell |
558
-21
| -4% | -$2.25K | 0.01% | 258 |
|
|
2016
Q3 | $73K | Buy |
579
+25
| +5% | +$3.09K | 0.02% | 224 |
|
|
2016
Q2 | $65K | Buy |
554
+6
| +1% | +$679 | 0.01% | 224 |
|
|
2016
Q1 | $57K | Sell |
548
-138
| -20% | -$13.3K | 0.01% | 256 |
|
|
2015
Q4 | $68K | Sell |
686
-3
| -0.4% | -$294 | 0.02% | 239 |
|
|
2015
Q3 | $63K | Sell |
689
-110
| -14% | -$11K | 0.02% | 243 |
|
|
2015
Q2 | $87K | Sell |
799
-57
| -7% | -$6.31K | 0.02% | 230 |
|
|
2015
Q1 | $98K | Sell |
856
-22
| -3% | -$2.51K | 0.02% | 205 |
|
|
2014
Q4 | $97K | Hold |
878
| – | – | 0.02% | 206 |
|
|
2014
Q3 | $86K | Buy |
878
+145
| +20% | +$14.3K | 0.02% | 217 |
|
|
2014
Q2 | $74K | Sell |
733
-1
| -0.1% | -$98 | 0.02% | 258 |
|
|
2014
Q1 | $67K | Sell |
734
-8
| -1% | -$737 | 0.02% | 277 |
|
|
2013
Q4 | $67K | Buy |
742
+493
| +198% | +$42.7K | 0.02% | 262 |
|
|
2013
Q3 | $20K | Sell |
249
-517
| -67% | -$40.7K | 0.01% | 470 |
|
|
2013
Q2 | $56K | Buy |
+766
| New | +$57.3K | 0.02% | 315 |
|
Other funds holding ZBH
Howe & Rusling's ZBH Position: Q4 2022 in Review
Howe & Rusling sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 521 shares — an estimated $54K sold.
Howe & Rusling first reported a position in ZBH in Q2 2013 and held it in 38 quarters. The position peaked at $98K in Q1 2015. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.
- Howe & Rusling reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
- Howe & Rusling sold 521 Zimmer Biomet shares in Q4 2022, an estimated $54K.
- Howe & Rusling first reported a position in Zimmer Biomet in Q2 2013 and held it in 38 quarters.
- Howe & Rusling's Zimmer Biomet position peaked at $98K in Q1 2015.
- 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.
Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.